Detection of HCV-specific sequences in chronic myopathy with hepatitis C: improvement with interferon-alpha 2A therapy.
Sola
P
P
Clinica Neurologica, Clinica Medica I, Università di Modena, Italia. sola.p@policlinico.mo.it
Galassi
G
G
Merelli
E
E
Ferrari
M G
MG
Sorgato
P
P
Ghini
M
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers; D004279:DNA, Viral / Q000302:isolation & purification; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D009135:Muscular Diseases / Q000821:virology*; D009460:Neurologic Examination; D011994:Recombinant Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D016896:Treatment Outcome
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins